D Boost Promised For Canada

OTTAWA -Scientists are cautiously optimistic that Canadian Prime Minister Brian Mulroney will deliver on a promise to spend an additional $1.3 billion Canadian ($ 1.014 billion U.S.) on federal science and technology initiative over the next five years. Mulroney made the announcement to 200 business and university leaders last month in Toronto at a federally sponsored conference called to solicit their advice or developing a new national science and technology strategy. A portion of the funds

Written byDavid Spurgeon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Mulroney made the announcement to 200 business and university leaders last month in Toronto at a federally sponsored conference called to solicit their advice or developing a new national science and technology strategy.

A portion of the funds Will help establish a program of centers of excellence on Canadian university campuses and a system of scholarships in science, engineering and related disciplines for some 2,500 undergraduates each year.

Skeptics have suggested that the bulk of the money Will be spent only if the prime minister's Progressive Conservative government is re-elected. An election must be held by September 1989. They also pointed out that Mulroney has not kept his promise to double what was referred to as collective spending on R&D as a proportion of GNP When the promise was made, six months before his party won a landslide election victory in September 1984, R&D spending stood at 1.3 percent of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies